Skip to main content
PLOS One logoLink to PLOS One
. 2023 Mar 15;18(3):e0283010. doi: 10.1371/journal.pone.0283010

A protocol for a systematic review of electronic early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms

Sharareh Rostam Niakan Kalhori 1,2,*, Thomas M Deserno 1, Mostafa Haghi 3, Nagarajan Ganapathy 1,4
Editor: Mohamed Yacin Sikkandar5
PMCID: PMC10016632  PMID: 36920960

Abstract

Background

This is a systematic review protocol to identify automated features, applied technologies, and algorithms in the electronic early warning/track and triage system (EW/TTS) developed to predict clinical deterioration (CD).

Methodology

This study will be conducted using PubMed, Scopus, and Web of Science databases to evaluate the features of EW/TTS in terms of their automated features, technologies, and algorithms. To this end, we will include any English articles reporting an EW/TTS without time limitation. Retrieved records will be independently screened by two authors and relevant data will be extracted from studies and abstracted for further analysis. The included articles will be evaluated independently using the JBI critical appraisal checklist by two researchers.

Discussion

This study is an effort to address the available automated features in the electronic version of the EW/TTS to shed light on the applied technologies, automated level of systems, and utilized algorithms in order to smooth the road toward the fully automated EW/TTS as one of the potential solutions of prevention CD and its adverse consequences.

Trial registration

Systematic review registration: PROSPERO CRD42022334988.

Introduction

Clinical deterioration (CD) is the physiological decompensation that occurs when a patient experiences a worsening condition or acute onset of a serious physiological disturbance. A deteriorated patient worsens his clinical state and increases morbidity and organ dysfunction, which incurs care escalation, a protracted hospital stay, or even death [1]. CD dynamically causes other primary and secondary adverse consequences (Fig 1) which can be prevented if timely detected [2]. Hence, healthcare systems are required to detect and control patients’ physiological decompensation, particularly in high-risk cases [2]. Recognition of patients affected by CD is a priority for many healthcare facilities. Clinicians may apply vital signs tracking tools to detect CDs in the frame of manual charts, scoring tools, or available electronic systems to detect and predict CDs. In this study, we focus on the electronic version of the early warning/track and triage system (EW/TTS).

Fig 1. Dynamic entities of clinical deterioration, primary and secondary consequences in case of improper medical intervention.

Fig 1

In 1997, Morgan and colleagues introduced the manual chart of early warning score (EWS) [3], and Maupin et al. reported that EWS in hospitals halves the rate of emergency code calls [4]. All EWS charts follow the same principle including a given threshold score, triggering a prescribed set of actions intended to escalate patient care [5]. The Royal College of Physicians recommended a standardized national EWS in the United Kingdom for all adult inpatients [6]. Early warning charts face limitations such as subjectivity, inadequate nursing skills, infrequent patient monitoring, poor documentation, and a lack of timely action at the time of CD [7, 8]. These restrictions inspired the care provider team in the hospital to improve scoring charts, switching from manual charts to an electronic early warning system called ‘early warning /track and triage system’ (EW/TTS) [911].

EW/TTS is designed based on monitoring patients’ vital signs since 85% of severe adverse events (SAE) happen after abnormal vitals [10]. To monitor and detect physiological clinical deterioration, most EW/TTS combine respiration rate, oxygen saturation level, supplementary oxygen flow rate, systolic blood pressure, heart rate, temperature, and level of consciousness parameters; some EW/TTSs use the Glasgow coma scale and pain scores too [12]. Staff in emergency departments (ED), ambulatory services, physicians and nurses in ICU and hospital wards [10], and maybe in future residences in smart ambient [13] use EW/TTS. However, the idea of using information technology and artificial intelligence for Electronic Health Records (EHR) connectivity and system automation was brought up by Whittington et al. by developing an automated risk assessment system in hospitals to identify CD-affected patients [14]. Later the idea of EW/TTS improvement was gradually directed toward combating the problems of “failure to identify”, “failure to rescue”, and “failure to escalate the level of care” for patients at CD risk automatically. Subbe et al. revealed that the deployment of EW/TTS for automated vital signs monitoring and notification at the time of CD is associated with significant improvements in key patient-centered clinical outcomes in hospital wards [15]. By using these systems, it is aimed to activate the rapid response team automatically and speed up the on-time admissions to the intensive care unit (ICU) [15]. Smith et al. conducted a systematic review and concluded the need for electronic system improvement and automation using modern technology to reduce the remaining uncertainty in applying EW/TTS for cardiac arrest and death practically [16].

Currently, many hospital wards and ICUs use patient monitoring tools for CD detection via either an EWS chart or electronic EW/TTS with or without automated features [12]. In addition, the EWS chart has been welcomed in community-based settings such as home, car, and elderly residence dwellings [17]. Also, automatic EW/TTS and embedded alerts are associated with an increase in the accuracy of CD detection from 81 to 100% [10]. Even low-level automated EW/TTS increased the clinical attendance for the patients with the higher early warning score and decreased mortality by approximately 8% in the study period [10]. Due to the high interest to use warning systems and positive signals obtained from applying automated EW/TTS, it seems the next steps are toward full automation EW/TTSs development. However, there might be limitations and challenges in this route. The dynamic entities of CD [1] may cause the current EW/TTS to provide a number of false alerts and then alert fatigue [18]. Furthermore, there are infrequent or delays in vital signs recording which can be resolved by the modern technology of automated capturing of the vital signs using a handheld device. To address solutions for these limitations, studies to apply intelligent algorithms and technologies to support critical decision-making related to CD detection and prediction started on the academic side [1922], there are, however, so much efforts required to use their results in systems improvement practically. To fulfill this aim, it is required to understand where we stand now to plan for the further step ahead. In the other words, it is expected that applying emerging technologies improve EW/TTS for advanced automated real-time monitoring, timely diagnosis, accurate warning at CD, and precise prediction of SAEs as early as possible. The internet of things (IoT) and artificial intelligence are crucial technologies to bridge the remaining gaps [23, 24]. The full automation of EW/TTS for vital signs monitoring and CD detection and prediction looks ideal, however, it is challenging [25]. Some studies are required to prepare the groundwork for fully automated system development before implementation. The system developers, researchers, users including patients and care providers, policymakers, and vendors need to know about the details of the available electronic EW/TTS in terms of their current situation of automation, applied algorithms, and technologies. This step is important to push them toward further automated EW/TTS.

There are several former reviews focused on the effect of EWS on CD detection [26], the ability of EW/TTS to predict CD [16], machine learning for CD prediction [24, 27], and specific wards in a hospital [28]. However, to plan the future pathway of electronic EW/TTS improvement for more efficient, timely, and accurate CD detection and prediction, we need to understand available automated features supported by technologies, machine learning, and deep learning algorithms in the artificial intelligence domain. Our study aims to develop a systematically review protocol of automated features, technologies, and algorithms of available EW/TTS for CD detection and prediction in various settings such as hospital wards, smart homes, smart cars, or other possible system deployments.

Methodology

This systematic review protocol was defined and reported based on the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) checklist [29]. It is registered in the International Prospective Register of Systematic Reviews (https://www.crd.york.ac.uk/PROSPERO, No.: CRD322838). The PRISMA-P for the protocols checklist is provided as supportive information (S1 Checklist).

Systematic review objectives and questions

There are nine objectives and questions that will be used to identify the quality of available electronic EW/TTS.

  • To identify the automated features of EW/TTS.

  • To identify the type of technology applied in EW/TTS.

  • To identify the clinical setting (hospital wards or other settings) that EW/TTS is used.

  • To identify the clinical parameters or vital signs that are monitored by EW/TTS.

  • To identify if EW/TTS monitoring the consequences of CD, including primary and secondary outcomes such as heart failure or death.

  • To identify EW/TTS standards (syntax, semantics) for connectivity with other systems such as EHR.

  • To identify whether EW/TTS is able to analyze collecting data for CD detection or prediction.

  • To identify applied algorithms for data analysis purposes in EW/TTS.

  • To identify the evaluation of EW/TTS and its data analytics methods.

Systematic review questions

  • Which automated features does the EW/TTS have?

  • What type of technologies in EW/TTS is applied?

  • For which settings (hospital wards or other settings) the EW/TTS are used?

  • Which clinical parameters or vital signs are monitored by EW/TTS?

  • What are the purposes of EW/TTS in terms of the primary and secondary consequences of CD?

  • Which standards are used for EW/TTS connectivity?

  • Is EW/TTS able to analyze data for CD detection or prediction?

  • Which algorithms are used for data analysis in EW/TTS?

  • What are the results of evaluating EW/TTS and its algorithms?

Type of participants

Those studies that reported an electronic EW/TTS with information about the system’s ability to monitor clinical parameters, CD occurrence, and primary or secondary consequences such as heart attack, heart failure, or death, possible automation features, the applied technology, setting including hospital wards (ED, ICU, other wards), clinic, or smart ambient, the applied standard for interoperability, the ability of data analysis, the applied algorithms including statistical, machine learning or deep learning methods to predict related outcomes, and the result of evaluating EW/TTS and its data analysis model.

Information resources

Databases such as PubMed, Web of science, and Google Scholar will be searched for documentation and no restrictions on the type of document will apply. The grey literature must be checked and the two clinical specialists in the area of emergency medicine must approve the sources of search. Initially, the keywords are determined and their synonyms are specified using MESH. Then, English keywords and their combinations will be searched in the aforementioned databases based on the title tag, summary, and keywords without time limitation. The syntax searched in the databases will be as the following section.

Search strategy

The search study has two main areas of concepts based on the study aims which are set to understand the technical details regarding the EW/TTS. It covers technological terminology AND clinical terminologies. The clinical terms were checked in MESH too. It is aimed to retrieve studies with common themes of the fields of information technology, monitoring systems, and artificial intelligence on one hand, and the fields of triage, emergency medicine, and clinical deterioration on the other hand. we use the following search terms on the title, abstract, and keywords:

( (’patient deterioration’) OR (’clinical deterioration’) OR (’instability’) OR (’failure to rescue’) OR (’early warning’)OR (’track and trigger’) OR (’decompensation’) OR (’heart attack’) OR (’heart failure’) OR (’pulmonary failure’) OR (’renal failure’) OR (’sepsis’) OR (’care escalation’) OR (’triage’) OR (’emergency’) OR (’warn*’) ) AND ( (’system*’) OR (’automat*’) OR (’smart*’) OR (’wearable*’) OR (’internet of thing*’) OR (’digital*’) OR (’signal*’) OR (’sensor*’) OR (intelligen*’) OR (prediction), (Expert system) ). This general strategy is updated for each database according to its syntax. For example, for search in Scopus, the strategy will be as follows:

(TITLE-ABS-KEY (’patient deterioration’) OR TITLE-ABS-KEY (’clinical deterioration’)) AND (TITLE-ABS-KEY (’instability’) OR TITLE-ABS-KEY (’failure to rescue’) OR TITLE-ABS-KEY (’early warning’) OR TITLE-ABS-KEY (’track and trigger’) OR TITLEABS-KEY (decompensation)) OR TITLEABS-KEY (’heart attack’) OR TITLEABS-KEY (’heart failure’) OR TITLEABS-KEY (’pulmonary failure’) OR TITLEABS-KEY (’renal failure’) OR TITLEABS-KEY (sepsis)) OR TITLEABS-KEY (’care escalation’) OR TITLEABS-KEY (triage) OR TITLEABS-KEY (emergency) OR TITLEABS-KEY (warn*)) AND (TITLE-ABS-KEY (system*) OR TITLE-ABS-KEY (automat*) OR TITLE-ABS-KEY (smart*) OR TITLE-ABS-KEY (wearable*)) OR TITLE-ABS-KEY (’internet of thing*’) OR TITLE-ABS-KEY (’digital*’) OR TITLE-ABS-KEY (’signal*’) OR TITLE-ABS-KEY (’sensor*’) OR TITLE-ABS-KEY (intelligen*) OR TITLE-ABS-KEY (prediction) OR TITLE-ABS-KEY (Expert system)).

Eligibility criteria

Inclusion criteria

  • All original papers are in the English language.

  • The works that report electronic systems for CD detection via human vital sign monitoring.

  • The studies that report electronic EW/TTS have already been developed and applied in the real world.

  • The reported EW/TTSs are applied either for physiological data monitoring or other risk factors of CD detection or monitoring.

  • The reported EW/TTS in any setting including hospital, clinic, or smart ambient.

  • The reported EW/TTS in every type including bed-connected systems, wearable devices, or unobtrusive sensing technologies.

Exclusion criteria

  • The reports of EW scoring charts manually calculate risk scores such as MEWS, EWS, PEWS, and MEWT.

  • All works are published in other languages than English.

  • Papers that only provide an abstract.

  • Study protocols and ongoing work descriptions.

  • Studies not providing any details on technologies, algorithms, or features of the system.

  • Studies that only report models or system designs or prototypes.

Selection process

After searching in the databases, we will transfer the results into an Endnote library and remove duplicates. Then, we will use the Covidence system (https://www.covidence.org) to support the next stages. The titles and summaries will be reviewed to find relevant studies. Subsequently, two experienced scholars specializing in the field of Biomedical Engineering or Medical Informatics will study the full texts independently. We will have group discussions for potential disagreements to resolve the contradictions via online group discussion. A third reviewer will be invited to solve the conflicts in case of further disagreement. To find other related studies, the snowball sampling technique will be used and accordingly, the references cited in the reviewed articles will be taken into account. Highly impact and credible related journals will also be assessed manually to find relevant papers disseminated during the last 10 years. Furthermore, systematic reviews and reference books, and legal documentation will also be checked for related records. Sharareh R. Niakan Kalhori will create an account, particularly for this review, and transfer the Endnote library into Covidence. She will invite other researchers to independently review the records at different levels of study. She will define the criteria and filter in Covidence before starting the study selection.

Data collection process

After completion of the selection process, the data from each record will be extracted and collected from the full text of the studies. Each study team member will extract data based on pre-designed variables defined in Covidence. The variables include the content of the ‘type of participants’ indicated earlier. In case of having difficulty collecting data from the full-text articles, the corresponding author of the study will be contacted through email to obtain the required data. The study’s data will be available after completing the review according to the journal policy publishing the final report.

Data synthesis and statistical analysis

Covidence provides enough options to analyze the results with descriptive parameters such as frequency and percentage, and it supports the generation of graphs. We will present the frequency/percentage of EW/TTS type, the automation feature, the clinical parameters or CD and its consequences to monitor, the applied technologies, algorithms, and evaluation results as available as possible. Furthermore, Covidence exports the spreadsheet of the extracted data and further statistical analysis can be done. There will be different variables such as type of EW/TTS, The group that the system is used for (pediatrics, pregnant women, elderly, and others), the condition or disease that the understudy group has, the monitored clinical parameters or vital signs, the primary and secondary consequences of the monitoring via EW/TTS, the automation features of EW/TTS, the applied technology for automation purposes, the connectivity to the other systems, the applied standards for connectivity, the applied algorithm for data analysis, the results of the algorithm evaluation, and the results of evaluation the EW/TTS. Based on the available variables, the descriptive analysis, including frequency and percentage parameters, will be calculated and presented in the frame of graphs and tables. In the result section, a narrative synthesis will be applied to describe and compare the paper’s results. Meta-analysis is not the aim of this systematic review due to the diversity of outcomes and results. Furthermore, correlation analysis between the country of applying EWS/TTS, the system type, the setting and the functionality of the system, the level of automation, applied algorithms, and the results of system or algorithm evaluation will be conducted. Furthermore, we will report the results of the quality assessment of studies in table format.

The results will be provided in the frame of tables, graphs, and numbers with related P-values. We will present the results of our study at relevant conferences and pursue publication in a relevant journal to disseminate findings to serve patients and relevant communities.

Study quality assessment

The Faculty of Health and Medical Sciences at the University of Adelaide, South Australia has created the JBI critical appraisal checklist (https://joannabriggs.org/), which includes nine main items involving the feasibility, appropriateness, meaningfulness, and effectiveness of healthcare studies [30]. We will use the version for cross-sectional studies.

Discussion

Artificial intelligence (AI) and related technologies are being increasingly applied to healthcare. These technologies have the potential to change many aspects of patient care due to the complexity and rise of data in healthcare. Several types of AI are already being employed such as automated diagnosis and treatment recommendations, patient engagement and adherence, and administrative activities [31]. Automation is attained from various technologies combination. Machine learning techniques as the most common forms of AI are used for predictive and classification model development through learning from historical training data [18]. The most complex forms of machine learning involve deep learning or neural network models with many levels of features or variables that predict outcomes [31]. Deep learning is also applied to predict CD and other SAE increasingly. Other technologies such as the internet of things (IoT) for patient data collection through sensing, a different form of natural language processing (NLP) for analyzing unstructured clinical notes on patients, expert systems based on collections of ‘if-then’ rules for decision-making support, and robots have become more collaborative with humans and are more easily trained by moving them through a desired task [14]. They are also becoming more intelligent as other AI capabilities are being embedded in their ‘brains’ (operating systems).

System intelligence and automation have a gradual trend and can be improved at different levels from the lowest to the full version. To enhance electronic EW/TTS, in a requirement analysis conducted in 2022, the potential technologies were demonstrated. It is revealed that an intelligent EW/TTS to monitor the patient for CD detection and automatically alarm the rapid response team requires five subsystems that need to be enhanced by proper technologies. They are patient monitoring systems, electronic health records, clinical decision support systems, remote monitoring patients, and dashboards &registries in an integrated approach using technologies of IoT, deep and machine learning techniques, big data, advanced databases, and standards to create an intelligent EW/TTS [32]. Fulfillment from theory to practice, particularly in the medical area which is a human-related discipline, may face difficulties and challenges. For example, some patients are not keen on the unwieldy vital sign monitoring machine being attached to them continuously. However, they may accept more comfortable and unobtrusive technologies. Other challenges of using AI in critical care such as facets of dependability, reproducibility, and ethics must be considered in the area of automated EW/TTS [33]. There are also benefits of applying an intelligent system for critical care in terms of decision-making aids based on prognosticating the course of the disease and adverse outcomes, patient flow, and hospital beds management, particularly in ICU, capturing complex non-linear relationships, and analysis and representation of unstructured data such as clinical notes [33]. Considering the two sides of the challenges and benefits of applying automated systems, further studies are required to show the justification of intelligent and automated EW/TTS development. The results of this systematic review may trigger a research line toward fully automated EW/TTS development and implementation. For decision-making toward full automation, we need to know where we stand now in terms of applied algorithms, technologies, system connectivity, and level of automation. Further studies are needed to demonstrate the effect of electronic and automated monitoring systems on patient-centric outcomes, and the challenges that may apply in this route. It is necessary to conduct enough studies prior to invest fund, time, and other resources. This review will systematically investigate the available EW/TTS focusing on automated features, technologies, and applied statistical or intelligent algorithms. The result of this study divulges the technical and automation level of current systems. Next generation of automated EW/TTS use the results of this systematic reviews beside applying the timely modern technologies for overcoming the limitations of current the systems.

Conclusion

Current systems of EW/TTS require further automation and improvement. To understand the current level of automation, applied technologies, and algorithms supporting all beneficiaries and stockholders, this systematic review will be conducted. The results may support developers, policymakers, and vendors moving toward higher-level systems for patient monitoring aimed at the timely detection and prediction of clinical deterioration and its adverse side effects.

Supporting information

S1 Checklist. PRISMA-P 2015 checklist.

(DOCX)

Acknowledgments

Special thanks to the Alexander von Humboldt Foundation, TU Braunschweig, and Tehran University of Medical Sciences to provide the opportunity for Sharareh R: Niakan Kalhori to conduct this research at PLRI of TU Braunschweig, Germany.

Abbreviation

EW/TTS

Early warning/track-and-trigger systems

JBI

Joanna Briggs Institute

MEWS

Modified Early Warning Score

EWS

Early Warning Score

PEWS

Paediatric early warning systems

MEWT

Maternal Early Warning System

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

SRNK received funds from Alexander von Humboldt Foundation (AVH). The reference number is 3.4-IRN-1185284-GF-E. The AVH website is https://www.humboldt-foundation.de. The funder has no role in the study design data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Padilla RM, Mayo AM. Clinical deterioration: A concept analysis. J Clin Nurs. 2018;27(7–8):1360–8. Epub 2017/12/22. doi: 10.1111/jocn.14238 . [DOI] [PubMed] [Google Scholar]
  • 2.Jones D, Mitchell I, Hillman K, Story D. Defining clinical deterioration. Resuscitation. 2013;84(8):1029–34. doi: 10.1016/j.resuscitation.2013.01.013 [DOI] [PubMed] [Google Scholar]
  • 3.Morgan R, Williams F, Wright M. An early warning scoring system for detecting developing critical illness. Clin Intensive Care. 1997;8(2):100. [Google Scholar]
  • 4.Maupin JM, Roth DJ, Krapes JM. Use of the Modified Early Warning Score decreases code blue events. Joint Commission Journal on Quality and Patient Safety. 2009;35(12):598–603. doi: 10.1016/s1553-7250(09)35084-9 [DOI] [PubMed] [Google Scholar]
  • 5.Gao H, McDonnell A, Harrison DA, Moore T, Adam S, Daly K, et al. Systematic review and evaluation of physiological track and trigger warning systems for identifying at-risk patients on the ward. Intensive care medicine. 2007;33(4):667–79. doi: 10.1007/s00134-007-0532-3 [DOI] [PubMed] [Google Scholar]
  • 6.Jones M. NEWSDIG: The national early warning score development and implementation group. Clinical medicine. 2012;12(6):501. doi: 10.7861/clinmedicine.12-6-501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Akre M, Finkelstein M, Erickson M, Liu M, Vanderbilt L, Billman G. Sensitivity of the pediatric early warning score to identify patient deterioration. Pediatrics. 2010;125(4):e763–e9. doi: 10.1542/peds.2009-0338 [DOI] [PubMed] [Google Scholar]
  • 8.Prytherch DR, Smith GB, Schmidt PE, Featherstone PI. ViEWS—towards a national early warning score for detecting adult inpatient deterioration. Resuscitation. 2010;81(8):932–7. doi: 10.1016/j.resuscitation.2010.04.014 [DOI] [PubMed] [Google Scholar]
  • 9.Cho K-J, Kwon O, Kwon J-m, Lee Y, Park H, Jeon K-H, et al. Detecting patient deterioration using artificial intelligence in a rapid response system. Critical care medicine. 2020;48(4):e285–e9. doi: 10.1097/CCM.0000000000004236 [DOI] [PubMed] [Google Scholar]
  • 10.Shiloh AL, Lominadze G, Gong MN, Savel RH, editors. Early warning/track-and-trigger systems to detect deterioration and improve outcomes in hospitalized patients. Seminars in Respiratory and Critical Care Medicine; 2016: Thieme Medical Publishers. [DOI] [PubMed] [Google Scholar]
  • 11.Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD. The 100 000 lives campaign: setting a goal and a deadline for improving health care quality. Jama. 2006;295(3):324–7. doi: 10.1001/jama.295.3.324 [DOI] [PubMed] [Google Scholar]
  • 12.Le Lagadec MD, Dwyer T. Scoping review: the use of early warning systems for the identification of in-hospital patients at risk of deterioration. Australian Critical Care. 2017;30(4):211–8. doi: 10.1016/j.aucc.2016.10.003 [DOI] [PubMed] [Google Scholar]
  • 13.Guo Y, Liu X, Peng S, Jiang X, Xu K, Chen C, et al. A review of wearable and unobtrusive sensing technologies for chronic disease management. Computers in Biology and Medicine. 2021;129:104163. doi: 10.1016/j.compbiomed.2020.104163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Whittington J, White R, Haig KM, Slock M. Using an automated risk assessment report to identify patients at risk for clinical deterioration. Joint Commission Journal on Quality and Patient Safety. 2007;33(9):569–74. doi: 10.1016/s1553-7250(07)33061-4 [DOI] [PubMed] [Google Scholar]
  • 15.Subbe CP, Duller B, Bellomo R. Effect of an automated notification system for deteriorating ward patients on clinical outcomes. Critical Care. 2017;21(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Smith MB, Chiovaro JC, O’Neil M, Kansagara D, Quiñones AR, Freeman M, et al. Early warning system scores for clinical deterioration in hospitalized patients: a systematic review. Annals of the American Thoracic Society. 2014;11(9):1454–65. doi: 10.1513/AnnalsATS.201403-102OC [DOI] [PubMed] [Google Scholar]
  • 17.Cicirelli G, Marani R, Petitti A, Milella A, D’Orazio T. Ambient assisted living: A review of technologies, methodologies and future perspectives for healthy aging of population. Sensors. 2021;21(10):3549. doi: 10.3390/s21103549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Romero-Brufau S, Whitford D, Johnson MG, Hickman J, Morlan BW, Therneau T, et al. Using machine learning to improve the accuracy of patient deterioration predictions: Mayo Clinic Early Warning Score (MC-EWS). Journal of the American Medical Informatics Association. 2021;28(6):1207–15. doi: 10.1093/jamia/ocaa347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gillies CE, Taylor DF, Cummings BC, Ansari S, Islim F, Kronick SL, et al. Demonstrating the consequences of learning missingness patterns in early warning systems for preventative health care: A novel simulation and solution. Journal of Biomedical Informatics. 2020;110:103528. doi: 10.1016/j.jbi.2020.103528 [DOI] [PubMed] [Google Scholar]
  • 20.Kamio T, Van T, Masamune K. Use of machine-learning approaches to predict clinical deterioration in critically ill patients: a systematic review. International Journal of Medical Research & Health Sciences. 2017;6(6):1–7. [Google Scholar]
  • 21.Kia A, Timsina P, Joshi HN, Klang E, Gupta RR, Freeman RM, et al. MEWS++: enhancing the prediction of clinical deterioration in admitted patients through a machine learning model. Journal of clinical medicine. 2020;9(2):343. doi: 10.3390/jcm9020343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.de Almeida FA, Ramos IC, Rutten-van Mölken M, Al M. Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure. Value in Health. 2021;24(10):1435–45. doi: 10.1016/j.jval.2021.04.004 [DOI] [PubMed] [Google Scholar]
  • 23.Da Costa CA, Pasluosta CF, Eskofier B, Da Silva DB, da Rosa Righi R. Internet of health things: toward intelligent vital signs monitoring in hospital wards. Artificial intelligence in medicine. 2018;89:61–9. doi: 10.1016/j.artmed.2018.05.005 [DOI] [PubMed] [Google Scholar]
  • 24.Al-Shwaheen TI, Moghbel M, Hau YW, Ooi CY. Use of learning approaches to predict clinical deterioration in patients based on various variables: a review of the literature. Artificial Intelligence Review. 2021:1–30.32836651 [Google Scholar]
  • 25.Kellett J. How much of NEWS could be measured by a machine, and would it work? Resuscitation. 2014;85(9):e147. Epub 20140606. doi: 10.1016/j.resuscitation.2014.05.028 . [DOI] [PubMed] [Google Scholar]
  • 26.McGaughey J, Fergusson DA, Van Bogaert P, Rose L. Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards. Cochrane Database of Systematic Reviews. 2021;(11). doi: 10.1002/14651858.CD005529.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Joshi M, Ashrafian H, Aufegger L, Khan S, Arora S, Cooke G, et al. Wearable sensors to improve detection of patient deterioration. Expert review of medical devices. 2019;16(2):145–54. doi: 10.1080/17434440.2019.1563480 [DOI] [PubMed] [Google Scholar]
  • 28.Despins LA. Automated deterioration detection using electronic medical record data in intensive care unit patients: a systematic review. CIN: Computers, Informatics, Nursing. 2018;36(7):323–30. doi: 10.1097/CIN.0000000000000430 [DOI] [PubMed] [Google Scholar]
  • 29.Moher D, Liberati A, Tetzlaff J, Altman DG, Group* P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009;151(4):264–9. [DOI] [PubMed] [Google Scholar]
  • 30.Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Military Medical Research. 2020;7(1):1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Matheny ME, Whicher D, Israni ST. Artificial intelligence in health care: a report from the National Academy of Medicine. Jama. 2020;323(6):509–10. doi: 10.1001/jama.2019.21579 [DOI] [PubMed] [Google Scholar]
  • 32.Rostam Niakan Kalhori S, Deserno TM. Requirement Analysis for an Intelligent Warning System to Alarm the Rapid Response Team Prior to Patient Deterioration. Stud Health Technol Inform. 2022;295:5–11. doi: 10.3233/SHTI220646 . [DOI] [PubMed] [Google Scholar]
  • 33.Datta R, Singh S. Artificial intelligence in critical care: its about time! Medical Journal Armed Forces India. 2021;77(3):266–75. doi: 10.1016/j.mjafi.2020.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mohamed Yacin Sikkandar

6 Sep 2022

PONE-D-22-10855A protocol for a systematic review of early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithmsPLOS ONE

Dear Dr. Sharareh Niakan Kalori,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Yacin Sikkandar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

title: Title reflects the scope of the study clearly

Abstract:

1. Too short and it looks like expanded title

2. Methodology, data management and its conclusions can be included

Introduction:

1. Necessity of this study is not clearly explained

Methodology

1. Is there any significance in using the suggested the Search Strategy?

2. Is there any significance in excluding Review articles and conference papers?

3. PICO strategy is used in this study - justification not provided

4. words such as Expert system, prediction could be added in search strategy

5. Technologies and algorithms are not discussed in this paper

General

- manuscript would be incomplete without discussing protocol efficiency 

- though it is a study protocol, challenges and limitations could also be presented

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: No

Reviewer #2: No

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: No

Reviewer #2: No

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

Reviewer #2: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I am unable to understand the significance of this work in its current form.

Authors have merely described some plan of action for performing a review on prediction of clinical deterioration.

Rather, it will be certainly interesting if the review has been actually performed and the findings are discussed in detail.

Reviewer #2: A review to predict clinical deterioration is performed using PRISMA. Following are the few questions to the authors:

1. CD is wide term, authors can try to be more specific

2. Authors have presented few results/observations from earlier publication. It is not clear what critical conclusions are arrived?

3. Authors have used different terms like: Features, AI, IoT etc. But no clear and indepth discussions are found. What is the inference drawn from this? How will it be useful for the future scientists/researchers?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 15;18(3):e0283010. doi: 10.1371/journal.pone.0283010.r002

Author response to Decision Letter 0


9 Nov 2022

Dear Editor of PLOS ONE

Thanks so much for the valuable comments on the manuscript (PONE-D-22-10855) entitled '' A protocol for a systematic review of early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms'' provided by reviewers. On behalf of the team of authors, I am writing the response to those comments which need reaction and correction. The changes are explained here in blue and presented as track changes in the text of the manuscript too. Furthermore, the revised clean version without track changes or highlights is submitted.

Editor's comments:

1. The abstract is too short and it looks like the expanded title. Methodology, data management, and conclusions can be included.

The abstract is extended with further necessary information.

2. In the Introduction, the necessity of this study is not clearly explained.

The necessity of the study is added in the introduction section.

3. In methodology, is there any significance in using the suggested Search Strategy?

The reason to use the search strategy was added in the Methodology section. The sample for Scopus is added too.

4. Is there any significance in excluding Review articles and conference papers?

Review articles and conference papers were added to the inclusion criteria. They may have useful information for our study. Thanks

5. PICO strategy is used in this study, but justification is not provided.

The PICO framework is removed as there is no clinical question based on an intervention here. However, other sections cover the required information regarding the EW/TTS systems, the criteria to compare them, and the possible outcomes considered.

6. Words such as Expert system, and prediction could be added to the search strategy.

They were added in the related part of the search strategy.

7. Technologies and algorithms are not discussed in this paper.

They are discussed in the discussion section, Thanks for the comment.

8. manuscript would be incomplete without discussing protocol efficiency.

The discussion part was improved, thanks for the comment.

9. Though it is a study protocol, challenges and limitations could also be presented.

challenges and limitations were added in the discussion part.

Reviews' Comments :

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: No

Reviewer #2: No

The rationale for the proposed study was added in the introduction. Also, the academic problem that will be answered is added more clearly at the end of the introduction.

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing of the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis that can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: No

Reviewer #2: No

The methodology section is extended and more details are added.

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

Reviewer #1: No

The methodology section is extended and more details are added.

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exceptions, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited in a public repository. For example, in addition to summary statistics, the data points behind means, medians, and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

We accept to provide the data available after completing the study according to the journal policy that will publish the final report. It is noted in the protocol too.

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

The whole manuscript was checked for errors and corrections.

Review Comments to the Author

Reviewer #1: I am unable to understand the significance of this work in its current form.

The authors have merely described some plan of action for performing a review on the prediction of clinical deterioration. Rather, it will be certainly interesting if the review has been actually performed and the findings are discussed in detail.

Reviewer #2: A review to predict clinical deterioration is performed using PRISMA. Following are a few questions for the authors:

1. CD is a wide term; authors can try to be more specific.

A more specific definition is provided in the introduction.

2. Authors have presented a few results/observations from earlier publications. It is not clear what critical conclusions arrive.

The introduction is improved and a clear conclusion from the review of studies was added.

3. Authors have used different terms like features, AI, IoT, etc. But no clear and in-depth discussions are found. What is the inference drawn from this? How will it be useful for future scientists/researchers?

The discussion section is added with details regarding the technologies, limitations, challenges, and future works.

Attachment

Submitted filename: Response_to_Reviewers.docx

Decision Letter 1

Mohamed Yacin Sikkandar

29 Nov 2022

PONE-D-22-10855R1A protocol for a systematic review of early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithmsPLOS ONE

Dear Dr. Sharareh Rostam Niakan Kalhori,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 13 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Yacin Sikkandar

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Statistical analysis of the outcome or any recommendation to the future researchers is not elaborated.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have implemented all the suggestions provided. The manuscript has been now modified with all required details.

Reviewer #2: Yes authors have addressed few of the reviewer's comments. Major portion of the paper talks on general introduction and review process. Statistical analysis of the outcome or any recommendation to the future researchers is not elaborated.

Few grammatical/typos can be looked into carefully.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 15;18(3):e0283010. doi: 10.1371/journal.pone.0283010.r004

Author response to Decision Letter 1


21 Dec 2022

Rebuttal Letter Round 2

Dear Editor of PLOS ONE

Thanks so much for the valuable comments on the manuscript (PONE-D-22-10855R1) entitled ''A protocol for a systematic review of early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms'' provided by reviewers. On behalf of the team of authors, I am writing the response to those comments which need reaction and correction. The changes are explained here in blue and presented as track changes in the text of the manuscript too. Furthermore, the revised clean version without track changes or highlights is submitted.

Journal Requirements :

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

All references were checked. Here there are the changes for the references:

The references 9 and 10 were replaced with each other. But still, we have both of them in the references.

References 21, 22, 23, 24, and 34 were added.

2. Statistical analysis of the outcome or any recommendation to future researchers is not elaborated.

The statistical analysis of the outcome and further studies suggestions were added in the discussion section.

Reviewers' comments:

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: No

The introduction section is revised to improve the study justifications. Also, in the discussion section, we added the provided knowledge by this study which can be the basis for further studies and system developments.

________________________________________

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

Reviewer #1: The authors have implemented all the suggestions provided. The manuscript has been now modified with all the required details.

Reviewer #2: Yes authors have addressed a few of the reviewer's comments. The major portion of the paper talks about the general introduction and review process. Statistical analysis of the outcome or any recommendation to future researchers is not elaborated.

The required improvements were applied in the introduction and discussion sections.

- Few grammatical/typos can be looked into carefully.

The whole paper was double-checked for grammatical/typos. Thanks for the comment.

The manuscript is really improved.

Thanks so much for the constructive comments.

Attachment

Submitted filename: Rebuttal Letter_round_2.docx

Decision Letter 2

Mohamed Yacin Sikkandar

27 Dec 2022

PONE-D-22-10855R2A protocol for a systematic review of electronic early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms

PLOS ONE

Dear Dr. Rostam Niakan Kalhori,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Statistical analysis part need to be explained more for better understandability of readers. 

==============================

Please submit your revised manuscript by Feb 10 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Yacin Sikkandar

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Statistical analysis Statistical analysis part need to be explained more for better understandability of readers.

Language can be further improved.

Referencing style can be formatted as per journal requirement.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 15;18(3):e0283010. doi: 10.1371/journal.pone.0283010.r006

Author response to Decision Letter 2


4 Jan 2023

Rebuttal Letter Round 3

Dear Editor of PLOS ONE

Thanks so much for the valuable comments on the manuscript (PONE-D-22-10855R1) entitled ''A protocol for a systematic review of early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms'' provided by reviewers. On behalf of the team of authors, I am writing the response to those comments which need reaction and correction. The changes are explained here in blue and presented as track changes in the text of the manuscript too. Furthermore, the revised clean version without track changes or highlights is submitted.

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

The whole references were rechecked and sorted based on the Journals format.

Additional Editor Comments:

1. Statistical analysis part needs to be explained more for better understandability of readers.

It is written with more explanation in more understandable version.

2. Language can be further improved.

The whole doc was rechecked and the text was improved.

3. Referencing style can be formatted as per journal requirements.

It is done.

Thanks very much.

Attachment

Submitted filename: Rebuttal Letter_round_3.docx

Decision Letter 3

Mohamed Yacin Sikkandar

1 Mar 2023

A protocol for a systematic review of electronic early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms

PONE-D-22-10855R3

Dear Dr. Rostam Niakan Kalhori,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohamed Yacin Sikkandar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mohamed Yacin Sikkandar

6 Mar 2023

PONE-D-22-10855R3

A protocol for a systematic review of electronic early warning/track-and-trigger systems (EW/TTS) to predict clinical deterioration: Focus on automated features, technologies, and algorithms

Dear Dr. Rostam Niakan Kalhori:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mohamed Yacin Sikkandar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA-P 2015 checklist.

    (DOCX)

    Attachment

    Submitted filename: Response_to_Reviewers.docx

    Attachment

    Submitted filename: Rebuttal Letter_round_2.docx

    Attachment

    Submitted filename: Rebuttal Letter_round_3.docx

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES